All Curated Mutation Sites in IV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in IV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
HA1
  
HA2
  
M1
  
M2
  
NA
  
NP
  
NS1
  
NS2
  
PA
  
PB1
  
PB2
  

Keyword: Influenza B-30792414
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 30792414 A62T
NA
NA
Influenza B
R
S
L
View
2 30792414 D384G
NA
NA
Influenza B
R
S
L
View
3 30792414 I120V
NA
NA
Influenza B
R
S
L
View
4 30792414 I45T
NA
NA
Influenza B
R
S
L
View
5 30792414 I45V
NA
NA
Influenza B
R
S
L
View
6 30792414 L73P
NA
NA
Influenza B
R
S
L
View
7 30792414 P42S
NA
NA
Influenza B
R
S
L
View
8 30792414 S41P
NA
NA
Influenza B
R
S
L
View
9 30792414 E313K
HA1
HA
Influenza B
R
S
L
View
10 30792414 K211R
HA1
HA
Influenza B
R
S
L
View
11 30792414 K299E
HA1
HA
Influenza B
R
S
L
View
12 30792414 L172Q
HA1
HA
Influenza B
R
S
L
View
13 30792414 L173Q
HA1
HA
Influenza B
R
S
L
View
14 30792414 L58P
HA1
HA
Influenza B
R
S
L
View
15 30792414 M251V
HA1
HA
Influenza B
R
S
L
View
16 30792414 M252V
HA1
HA
Influenza B
R
S
L
View
17 30792414 R278K
HA1
HA
Influenza B
R
S
L
View
18 30792414 R279K
HA1
HA
Influenza B
R
S
L
View
19 30792414 I117V
HA
HA
Influenza B
R
S
L
View
20 30792414 I146V
HA
HA
Influenza B
R
S
L
View
21 30792414 N116K
HA
HA
Influenza B
R
S
L
View
22 30792414 N129D
HA
HA
Influenza B
R
S
L
View
23 30792414 N129S
HA
HA
Influenza B
R
S
L
View
Contents
Description

The table shows all curated mutation sites of IV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.